CorMedix, Inc. (CRMD)
11.61
+0.35
(+3.11%)
USD |
NASDAQ |
Dec 09, 16:00
11.52
-0.09
(-0.78%)
After-Hours: 16:51
CorMedix EPS Diluted (Quarterly): 1.259 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Alkermes Plc | 0.4911 |
| Talphera, Inc. | -0.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.56M |
| Revenue (Quarterly) | 104.28M |
| Total Expenses (Quarterly) | -4.288M |
| Enterprise Value | 835.84M |
| Gross Profit Margin (Quarterly) | 89.26% |
| Earnings Yield | 17.68% |
| Operating Earnings Yield | 12.41% |
| Normalized Earnings Yield | 17.64 |